Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2098 (LINC02098)

Target: LINC02098
Molecular classification: Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA) [lincRNAs are a subtype of lncRNAs][5]

Overview

Long intergenic non-protein coding RNA 2098 (LINC02098) is a gene that encodes a non-protein-coding RNA transcript, classified as a long intergenic non-coding RNA (lincRNA)[1][3]. LincRNAs are a type of long non-coding RNA that are distinct from protein-coding genes and do not overlap annotated coding regions[5]. They typically have regulatory functions, such as influencing gene expression through chromatin remodeling, acting as enhancers, or modulating RNA stability and transcription. While many lincRNAs have been linked to tissue-specific gene regulatory roles and some have been implicated in disease, there is currently no direct evidence associating LINC02098 with specific biological functions, disease pathogenesis, or clinical utility as a therapeutic target in the literature or gene databases as of this search[1][3][5].

Other names: RP11-702B10.1LINC02098long intergenic non-protein coding RNA 2098

Biological functions

Regulation of gene expression (primarily through chromatin remodeling, genome architecture modulation, RNA stabilization, transcription regulation, and enhancer-associated activities)[5]Other (function specific to LINC02098 not documented, general lincRNA functions inferred)[5][1][3]

Disease associations

Other (There are no specific disease associations or roles in cancer, inflammation, neurodegeneration, or cardiovascular disease reported for LINC02098 in available sources)[1][3]

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2098 (LINC02098).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2098 (LINC02098).

Explore the full profile